Subramanian, AnuradhaaLee, Siang IngSudasinghe, Sudasing Pathirannehelage Buddhika HemaliWambua, StevenPhillips, KatherineSingh, MeghaAzcoaga-Lorenzo, AmayaCockburn, NeilWang, JingyaFagbamigbe, AdeniyiUsman, MuhammadDamase-Michel, ChristineYau, ChristopherKent, LisaMcCowan, ColinOReilly, DermotSantorelli, GillianHope, HollyKennedy, JonathanMhereeg, MohamedAbel, Kathryn MaryEastwood, Kelly-AnnBlack, MaireadLoane, MariaMoss, NgawaiBrophy, SineadBrocklehurst, PeterDolk, HelenNelson-Piercy, CatherineNirantharakumar, Krishnarajah2023-10-182023-10-182023-10-09Subramanian, A, Lee, S I, Sudasinghe, S P B H, Wambua, S, Phillips, K, Singh, M, Azcoaga-Lorenzo, A, Cockburn, N, Wang, J, Fagbamigbe, A, Usman, M, Damase-Michel, C, Yau, C, Kent, L, McCowan, C, OReilly, D, Santorelli, G, Hope, H, Kennedy, J, Mhereeg, M, Abel, K M, Eastwood, K-A, Black, M, Loane, M, Moss, N, Brophy, S, Brocklehurst, P, Dolk, H, Nelson-Piercy, C & Nirantharakumar, K 2023, 'Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy : A signal detection study protocol', BMJ Open, vol. 13, no. 10, e073162. https://doi.org/10.1136/bmjopen-2023-0731622044-6055Bibtex: Subramaniane073162ORCID: /0000-0001-9184-8258/work/145112960https://hdl.handle.net/2164/21951This work is independent research funded by the Strategic Priority Fund 'Tackling multimorbidity at scale' programme (grant number MR/W014432/1) delivered by the Medical Research Council and the National Institute for Health Research in partnership with the Economic and Social Research Council and in collaboration with the Engineering and Physical Sciences Research Council. The views expressed are those of the author and not necessarily those of the funders, the NIHR or the UK Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.This work was also supported by Health Data Research UK (HDRUK2023.0030), which is funded by UK Research and Innovation, the Medical Research Council, the British Heart Foundation, Cancer Research UK, the National Institute for Health and Care Research, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, Health and Care Research Wales, Health and Social Care Research and Development Division (Public Health Agency, Northern Ireland), Chief Scientist Office of the Scottish Government Health and Social Care Directorates11771434engR MedicineMedical Research Council (MRC)MR/W014432/1HDRUK2023.0030UK Research and Innovation (UKRI)HDRUK2023.0030RDetection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy : A signal detection study protocolJournal article10.1136/bmjopen-2023-073162https://bmjopen.bmj.com/content/13/10/e0731621310